Dr. Michael Har-Noy has spent the bulk of his scientific career researching and developing a new approach to cancer treatment. His company, Immunovative Therapies, is a graduate of...view moreDr. Michael Har-Noy has spent the bulk of his scientific career researching and developing a new approach to cancer treatment. His company, Immunovative Therapies, is a graduate of the Misgav Venture Accelerator, a member of the Israel technological incubator program that finances groundbreaking new scientific companies. As a member of this program, Immunovative Therapies Ltd. secured a $300,000 grant from the Office of the Chief Scientist in Israel. Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, continue to work towards a Phase II/III trial of their new immunologic treatment.view less